- Nachrichtendetail
-
16.05.2024 12:49:33 - dpa-AFX: *ARVINAS, PFIZER ANNOUNCE UPDATED CLINICAL DATA FROM PHASE 1B TRIAL OF VEPDEGESTRANT WITH PALBOCICLIB
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | 852009 | NYSE | 28,660 | 31.05.24 03:06:32 | +0,460 | +1,63% | 28,680 | 28,740 | 28,340 | 28,660 |
